您即将离开沛嘉医疗中文官网。
您刚才点击了进入另一网站的链接。如果继续,您可能会进入由第三方运行的网站。 我们不负责对非沛嘉医疗中文官网上的内容进行审核与管控,亦不会对您在非沛嘉医疗中文网上的任何商业交易或事物承担任何责任。您使用其他网站时,必须遵循该网站的使用条款及隐私声明。 其他网站上的部分产品和信息可能并未在您所在地区或国家获得批准。
取消
继续
Brief News on Innovation
Company News Brief News on Innovation
Brief News on Innovation
China-Developed Non-glutaraldehyde Crosslinked Dry-tissue TAVR System TaurusNXT Debuted at TCT
2025.11.01
China-Developed Non-glutaraldehyde Cross···
On October 27, Professor Pan Wenzhi from Zhongshan Hospital, representing the teams of Academician G···
Smart implant for Pressure-Guided Heart Failure Decongestion Won TCT 2025 Shark Tank Innovation Award
2025.10.31
Smart implant for Pressure-Guided Heart ···
At TCT 2025, Relief Cardiovascular, a company from the inQB8 incubator, won the Shark Tank innovatio···
TaurusTrio Experience in Ultra-Large Annulus Pure Regurgitation Presented at TCT
2025.10.29
TaurusTrio Experience in Ultra-Large Ann···
Professor Song Guangyuan from Beijing Anzhen Hospital Capital Medical University, presented one-year···
Professor Wang Yan Unveiled Groundbreaking Results of World's First Robot-Assisted TAVR EFS Trial
2025.10.29
Professor Wang Yan Unveiled Groundbreaki···
At TCT 2025, Professor Wang Yan from Xiamen Cardiovascular Hospital was invited to deliver a keynote···
3-Year Clinical Data of HighLife TSMVR: Significant Annulus Reduction and Left Ventricular Reverse Remodeling Observed
2025.10.28
3-Year Clinical Data of HighLife TSMVR: ···
Professor Wolfgang Rottbauer from Ulm University Heart Center presented 3-year results from the High···
NTCVR Multicenter Study Confirmed Safety and Efficacy of Taurus NCPI Technology in Pure Regurgitation Intervention
2025.10.28
NTCVR Multicenter Study Confirmed Safety···
At TCT 2025, Professor Zhang Xiaochun from Zhongshan Hospital, representing the teams of Academician···
FIRST IMPLANTATION IN THE FIM CLINICAL TRIAL OF Sutra Hemi-valve TRANSCATHETER MITRAL VALVE REPAIR SYSTEM
2025.09.12
FIRST IMPLANTATION IN THE FIM CLINICAL T···
This announcement is made by Peijia Medical Limited (the “Company”, together with itssubsidiaries, t···
Peijia Medical’s Hydrophilic Coating Guidewire  Received Registration Approval
2025.08.04
Peijia Medical’s Hydrophilic Coating Gui···
On July 30, 2025, Peijia Medical independently developed hydrophilic coating guidewire —specifically···
FIRST PATIENT IMPLANT IN THE GLOBAL CLINICAL STUDYOF THE MonarQ TTVR® SYSTEM
2025.07.16
FIRST PATIENT IMPLANT IN THE GLOBAL CLIN···
This announcement is made by Peijia Medical Limited (the “Company”, together with itssubsidiaries, t···
Peijia Medical Showcased Innovative Portfolio  at Beijing Valves 2025
2025.07.09
Peijia Medical Showcased Innovative Port···
From July 2 to 6, 2025, Peijia Medical made a remarkable appearance at Beijing Valves with a range···
China’s Independently Developed TEER   GeminiOne Gained Further Evidence:  Comparative Hemodynamic and  Biomechanical Evaluation
2025.07.02
China’s Independently Developed TEER G···
In July 2025, Dr. Jianfeng Chen, leading the R&D team at Peijia Medical, collaborated with Pro···
OCC 2025 One-Year Follow-Up Results from Pivotal Trial of TaurusNXT® Non-glutaraldehyde Crosslinked DrytissueTAVR System Released
2025.05.24
OCC 2025 One-Year Follow-Up Results from···
From May 29 to June 1, 2025, the 19th Oriental Congress of Cardiology (OCC 2025) grandly commenced a···
Top